Adverum Biotechnologies Email Format

Biotechnology ResearchCalifornia, United States51-200 Employees

Adverum Biotechnologies is a clinical-stage biotechnology company based in Redwood City, California, focused on developing gene therapies for highly prevalent ocular diseases. It is a wholly owned subsidiary of Eli Lilly and Company. The company seeks treatments that can be administered in a physician's office with a single, durable dose, reducing the need for frequent ocular injections.

Its lead program, ixoberogene soroparvovec, is being evaluated as a one-time injection for neovascular, or wet, age-related macular degeneration. In the biotechnology landscape, the company aims to advance a standard of care for vision-threatening conditions. The products are directed toward clinicians treating ocular diseases and patients dealing with wet AMD, with the aim of preserving vision.

Sign up for free to view info

Company overview Employee directory